☆ 4.6 Review

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

LANCET RESPIRATORY MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Medicine, General & Internal

Booster Vaccination to Prevent COVID-19 in the Era of Omicron An Effective Part of a Layered Public Health Approach

Saad B. Omer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi et al.

Summary: Assessing the performance of COVID-19 vaccines against the Omicron variant is crucial for public health guidance. This study found that receiving three doses of mRNA COVID-19 vaccine was associated with a lower likelihood of symptomatic SARS-CoV-2 infection compared to being unvaccinated or receiving two doses. These findings suggest that three doses of mRNA vaccine provide protection against both Omicron and Delta variants, though the protection against Omicron may be slightly lower.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Matthew E. Oster et al.

Summary: Based on reports in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased, especially among adolescent males and young men, particularly after the second dose. This risk should be considered in the context of the benefits of COVID-19 vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Hypersensitivity myocarditis and COVID-19 vaccines

Nicholas G. Kounis et al.

KARDIOLOGIA POLSKA (2022)

添加到收藏夹

Article Medicine, General & Internal

Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data

Lucy A. McNamara et al.

Summary: The initial roll-out of the US COVID-19 vaccination program was associated with reductions in COVID-19 cases, emergency department visits, and hospital admissions among older adults.

LANCET (2022)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

Stephane Heymans et al.

Summary: The risk of acute myocarditis associated with COVID-19 mRNA vaccination is rare and usually resolves quickly, while the risks of hospitalization and death from COVID-19 are greater. Therefore, COVID-19 vaccination is recommended for adolescents and adults.

NATURE REVIEWS CARDIOLOGY (2022)

添加到收藏夹

Letter Immunology

Post RNA-based COVID vaccines myocarditis: Proposed mechanisms

Kamran Kadkhoda

VACCINE (2022)

添加到收藏夹

News Item Critical Care Medicine

Omicron variant and booster COVID-19 vaccines

Talha Khan Burki

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Daniel Marrama et al.

Summary: The study found no evidence to support the idea that increased occurrences of myocarditis after the SARS-CoV-2 spike vaccination are due to a cross-reactive immune response.

EBIOMEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

The Evaluation of Oxidative Stress in the Young Adults with COVID-19 mRNA Vaccines Induced Acute Pericarditis- Myopericarditis

Ali Dogan Dursun et al.

Summary: This study found that vaccine-induced myopericarditis is associated with abnormalities in oxidative stress tests, while there is no relationship between NO levels and other oxidative stress tests in vaccine-induced acute pericarditis. This suggests that vaccine-induced pericarditis and myopericarditis may have different pathogenesis.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

添加到收藏夹

Article Environmental Sciences

COVID-19-Vaccination-Induced Myocarditis in Teenagers: Case Series with Further Follow-Up

Mateusz Puchalski et al.

Summary: COVID-19 vaccine-induced myocarditis can occur in teenagers aged 15 to 17 years with obesity/overweight. Although the symptoms are mild and recovery is fast, the inflammatory process may take more than 3 months to completely resolve.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Review Emergency Medicine

Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines

Brit Long et al.

Summary: This review summarized the background, evaluation, and management of vaccine-induced immune thrombotic thrombocytopenia (TTS). TTS is mainly associated with the Oxford-AstraZeneca and Johnson & Johnson vaccines, characterized by thrombosis and thrombocytopenia, with a low overall incidence.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR)

Daniel E. Clark et al.

CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury

Ludwig T. Weckbach et al.

Summary: In this study, myocardial injury in COVID-19 patients was documented through reduced left ventricular strain on echocardiography, myocarditis patterns on cardiac magnetic resonance, and increased macrophage numbers on endomyocardial biopsy.

CIRCULATION-CARDIOVASCULAR IMAGING (2021)

添加到收藏夹

Article Medicine, General & Internal

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde et al.

Summary: This study evaluated the association between mRNA COVID-19 vaccines and COVID-19 hospitalization, as well as disease progression to critical illness among hospitalized patients. The results showed that vaccination with mRNA COVID-19 vaccines significantly decreased the likelihood of COVID-19 hospitalization and disease progression to death or mechanical ventilation.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex

Noa Dagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Suspected myocarditis in patients with COVID-19 A multicenter case series

Natascia Lagana et al.

Summary: This study retrospectively evaluated 1169 COVID-19 patients admitted to three Italian Medicine wards and found that patients with suspected myocarditis were typically older, had a higher prevalence of previous cardiac disease, longer hospital stays, and lower interleukin-6 levels. Further studies are needed on this issue.

MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019

Denis Doyen et al.

Summary: This study investigated the cardiac abnormalities and their time course in critically ill COVID-19 patients. It found that cardiac injury is common and early in ICU patients, with ECG or echocardiographic signs of LV abnormalities being the most frequent, and patients with cardiac injury experiencing more RV systolic dysfunction than LV.

CHEST (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes Results of an Algorithm-Guided Screening

Benjamin S. Hendrickson et al.

CIRCULATION (2021)

添加到收藏夹

Review Immunology

US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

Diane Gubernot et al.

Summary: The COVID-19 pandemic has led to global collaborative efforts to develop vaccines, with mass vaccination campaigns underway in multiple countries. Monitoring vaccine safety and understanding background incidence rates are crucial for assessing adverse events related to vaccination.

VACCINE (2021)

添加到收藏夹

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Letter Emergency Medicine

Myopericarditis in young adults presenting to the emergency department after receiving a second COVID-19 mRNA vaccine

Alex Fleming-Nouri et al.

ACADEMIC EMERGENCY MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Myocarditis With COVID-19 mRNA Vaccines

Biykem Bozkurt et al.

Summary: Myocarditis is a rare complication of COVID-19 mRNA vaccines, predominantly affecting young adult and adolescent males, with most patients showing improvement in symptoms. Possible mechanisms include molecular mimicry between viral proteins and self-antigens, dysregulated immune pathways, immune response to mRNA, and dysregulated cytokine expression.

CIRCULATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients

Benjamin J. R. Buckley et al.

Summary: This study found that patients with COVID-19 who develop myocarditis/pericarditis have an increased risk of major adverse events and new-onset cardiovascular sequelae.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Myocarditis and Pericarditis After Vaccination for COVID-19

George A. Diaz et al.

Summary: This study compares the incidence of myocarditis and pericarditis in emergency department or inpatient hospital encounters before and during the period of COVID-19 vaccination availability in a large US health care system.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

The incidence of cardiac complications in patients hospitalised with COVID-19 in Australia: the AUS-COVID study

Kunwardeep S. Bhatia et al.

MEDICAL JOURNAL OF AUSTRALIA (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Tegan K. Boehmer et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Jay Montgomery et al.

Summary: This study investigated cases of myocarditis occurring in male patients within the US Military Health System after receiving mRNA COVID-19 vaccines between January and April 2021. A total of 23 male patients presented with acute chest pain within 4 days post-vaccination, with elevated troponin levels and findings consistent with myocarditis on imaging. The number of cases observed was higher than expected after a second dose of the vaccine among male military members.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection Results From the Big Ten COVID-19 Cardiac Registry

Curt J. Daniels et al.

Summary: In this study of 1597 competitive athletes in the US who underwent CMR screening after COVID-19 infection, 37 athletes (2.3%) were diagnosed with clinical and subclinical myocarditis. There was variability in prevalence across universities, and testing protocols were closely associated with the detection of myocarditis. The unique CMR imaging data highlight the need for standardized timing and interpretation of cardiac testing for safe return to play in athletes.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19

Antonin Trimaille et al.

Summary: Data from the Critical COVID France (CCF) study showed that young patients aged 18-45 years old hospitalized for COVID-19 had a lower incidence of primary outcomes, such as transfer to the ICU or in-hospital death, compared to older patients. However, they were more likely to experience cardiovascular complications like pericarditis and myocarditis. This suggests that while young patients have a better prognosis in terms of severe outcomes, COVID-19 may have a particular impact on their cardiovascular system.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The incidence of myopericarditis in patients with COVID-19

Atoosa Mostafavi et al.

Summary: This study evaluated myopericarditis in 404 patients with definite diagnosis of COVID-19, finding that 5 patients developed symptoms of myopericarditis without late presentation. Myopericarditis, pericardial effusion, and cardiac tamponade are rare complications of COVID-19, occurring in about 1.2% of cases, but should be considered as a possible cause of hemodynamic deterioration.

JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance

Hui Wang et al.

Summary: Myocardial injury was found in 30% of recovered COVID-19 patients, with LGE lesions mainly located in the mid myocardium and/or sub-epicardium. Patients with LGE showed decreased LV and RV function compared to non-LGE patients, while no difference was found between non-LGE patients and healthy controls.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2021)

添加到收藏夹

Review Infectious Diseases

The state of vaccine safety science: systematic reviews of the evidence

Matthew Z. Dudley et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study

John Hansen et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

COVID-19 Myocardial Injury in Survivors

Daniel S. Knight et al.

CIRCULATION (2020)

添加到收藏夹

Article Infectious Diseases

Cardiac manifestations of COVID-19 in Shenzhen, China

Jia-Hui Zeng et al.

INFECTION (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China

Qing Deng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Prognostic Value of Troponin Elevation in COVID-19 Hospitalized Patients

Elena-Mihaela Cordeanu et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac complications in patients hospitalised with COVID-19

Marijke Linschoten et al.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular complications and its impact on outcomes in COVID-19

Shekhar Kunal et al.

INDIAN HEART JOURNAL (2020)

添加到收藏夹

Article Mathematical & Computational Biology

Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions

Guido Schwarzer et al.

RESEARCH SYNTHESIS METHODS (2019)

添加到收藏夹

Article Immunology

Myocarditis and pericarditis are rare following live viral vaccinations in adults

Jennifer Kuntz et al.

VACCINE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Trends in acute pericarditis hospitalizations and outcomes among the elderly in the USA, 1999-2012

Purav Mody et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2018)

添加到收藏夹

Article Immunology

Hospitalizations within 14 days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012

Alexander J. Millman et al.

VACCINE (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Acute Pericarditis-Associated Hospitalization in the USA: A Nationwide Analysis, 2003-2012

Nilay Kumar et al.

CARDIOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

Alfonso Iorio et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Medicine, General & Internal

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

Alfonso Iorio et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Multidisciplinary Sciences

A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination

Renata J. M. Engler et al.

PLOS ONE (2015)

添加到收藏夹

Article Health Care Sciences & Services

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

Zachary Munn et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

添加到收藏夹

Article Immunology

Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System

Michael M. McNeil et al.

VACCINE (2014)

添加到收藏夹

Article Public, Environmental & Occupational Health

Metaprop: a Stata command to perform meta-analysis of binomial data

Victoria N. Nyaga et al.

ARCHIVES OF PUBLIC HEALTH (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood

Ville Kyto et al.

HEART (2013)

添加到收藏夹

Article Medicine, General & Internal

Myopericarditis and Pericarditis in the Deployed Military Member: A Retrospective Series

Andrew H. Lin et al.

MILITARY MEDICINE (2013)

添加到收藏夹

Article Health Care Sciences & Services

GRADE guidelines: 7. Rating the quality of evidence-inconsistency

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

添加到收藏夹

Article Immunology

Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003

Mercedes M. Sniadack et al.

CLINICAL INFECTIOUS DISEASES (2008)

添加到收藏夹

Article Public, Environmental & Occupational Health

Comparison of military and civilian reporting rates for smallpox vaccine adverse events

A. W. McMahon et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)

添加到收藏夹

Article Public, Environmental & Occupational Health

Myopericarditis following smallpox vaccination

MK Arness et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination

RE Eckart et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

添加到收藏夹

Article Medicine, General & Internal

US military smallpox vaccination program experience

JD Grabenstein et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

添加到收藏夹

Article Medicine, General & Internal

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

JS Halsell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.